The ideal vaccine to prevent cardiovascular disease
- PMID: 36638781
- DOI: 10.1093/eurheartj/ehac826
The ideal vaccine to prevent cardiovascular disease
Conflict of interest statement
Conflict of interest: Dr. Fröbert reported receiving speakers fee from Sanofi Pasteur. Dr. Cajander reported no conflicts of interest. Dr. Udell reported receiving support from a Government of Ontario Early Researcher Award (grant No. ER15-11-037), Women's College Research Institute and Department of Medicine, Women's College Hospital; he reported receiving grant support to his institutions from AstraZeneca, Novartis, and Sanofi; he reported service as a consultant for Amgen, Boehringer Ingelheim, Janssen, Merck, Novartis, and Sanofi; and he has received honoraria from Boehringer Ingelheim and Janssen.
Comment on
-
Primary prevention of acute cardiovascular events by influenza vaccination: an observational study.Eur Heart J. 2023 Feb 14;44(7):610-620. doi: 10.1093/eurheartj/ehac737. Eur Heart J. 2023. PMID: 36537199 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical